Doolittle Russell F
Center for Molecular Genetics, University of California, San Diego, La Jolla 92093, USA.
Blood Rev. 2003 Mar;17(1):33-41. doi: 10.1016/s0268-960x(02)00060-7.
During the past several years, a number of crystal structures have been determined of fragments from fibrinogen and fibrin and, most recently, a structure of a native fibrinogen. One feature of the fibrinogen molecule that has emerged from these studies has to do with its "loose ends," segments of the molecule that are extremely mobile and not discernable by X-ray crystallography. Some, if not all, of this flexibility is functionally important. Small synthetic peptides based on mobile parts of fibrinogen exposed by the action of thrombin have contributed significantly to these studies and may yet prove useful therapeutically. In the end, although crystal structures have added greatly to our understanding of fibrin formation, much still needs to be unraveled about how clots form.
在过去几年里,已经确定了纤维蛋白原和纤维蛋白片段的一些晶体结构,最近还确定了天然纤维蛋白原的结构。这些研究中出现的纤维蛋白原分子的一个特征与其“松散末端”有关,即分子中极其灵活且无法通过X射线晶体学识别的片段。这种灵活性中的一些(如果不是全部的话)在功能上很重要。基于凝血酶作用下暴露的纤维蛋白原可移动部分的小合成肽对这些研究做出了重大贡献,并且可能在治疗上仍然有用。最后,尽管晶体结构极大地增进了我们对纤维蛋白形成的理解,但关于凝块如何形成仍有许多需要阐明的地方。